Attorneys

Adolph C. Bohnstedt, Ph.D.

Adolph C. Bohnstedt, Ph.D.

Associate

Office: Albany | 518-452-5600 linkedin

adolph.bohnstedt@nullhrfmlaw.com | vCard

Adolph brings 14 years of experience as a research chemist in the pharmaceutical industry, 2 years of experience teaching chemistry at the college level, and 4 years of experience in the preparation and prosecution of patent applications as a registered patent agent.

Adolph’s research experience in industry includes hit discovery via combinatorial chemistry libraries, hit-to-lead, lead optimization, and process research on small molecule compounds. The targets of his research include kinase inhibitors (Lck, JAK3, and c-MET), GPCRs (CB-1 and CXCR2), and the transporter GlyT2.

Adolph has taught Basic Chemistry, Organic Chemistry I and II, and Introductory Biochemistry at SUNY-Adirondack and Franklin Pierce University.

Adolph’s current focus is the preparation and prosecution of patents protecting small molecule therapeutics.

  • “Synthesis Studies on Cephalotaxus Alkaloids” Ken S. Feldman and Adolph C. Bohnstedt at the 211th ACS National Meeting, New Orleans, LA, March 24-28 (1996), ORGN 056.
  • “Synthesis of Conformationally Constrained Analogues of Cyclosporin A” A. C. Bohnstedt and D. H. Rich at the 207th ACS National Meeting, San Diego, CA, March 13-17 (1994), ORGN 037.
  • “The Synthesis of Trans- and Cis-alkene Dipeptide Isosteres for Incorporation into Cyclosporin A Analogs” A. C. Bohnstedt, J. V. N. Vara Prasad, and D. H. Rich at the 206th ACS National Meeting, Chicago, IL, August 22-27 (1993), ORGN 304.
  • “2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors” Bioorg. Med. Chem. Lett. 2009, 19, 6788-6792.
  • “Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists” Bioorg. Med. Chem. Lett. 2006, 16, 2724-2728.
  • “2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors” Bioorg. Med. Chem. Lett. 2004, 14, 545-548.
  • “Inter- and Intramolecular Addition/Cyclizations of Sulfonamide Anions with Alkynyliodonium Triflates. Synthesis of Dihydropyrrole, Pyrrole, Indole, and Tosylenamide Heterocycles” Ken S. Feldman, Michelle M. Bruendl, Klaas Schildknegt, and Adolph C. Bohnstedt J. Org. Chem. 1996, 61, 5440-5452.
  • “Intramolecular Bicyclizations of Tosylamide-Containing Alkynyliodonium Salts as an Efficient Entry into Polycyclic Alkaloid Skeleta” Klaas Schildknegt, Adolph C. Bohnstedt, Ken S. Feldman, and Aruna Sambandam J. Am. Chem. Soc. 1995, 117, 7544-7545.
  • “Differential Sensitivity of Cyclosporin A Amide Bonds for Inhibition of Cyclophilin” A. C. Bohnstedt, G. R. Flentke, and D. H. Rich In Peptides: Chemistry-Structure-Biology. Proceedings of the 14th American Peptide Symposium; Kaumaya, Pravin T. P., Hodges, Robert S., Eds.; Mayflower Scientific: Kingswinford, UK, 1996; pp 705-706.
  • “Synthesis of E- and Z-alkene Dipeptide Isosteres” Adolph C. Bohnstedt, J. V. N. Vara Prasad, and Daniel H. Rich Tetrahedron Lett. 1993, 34, 5217-5220.
  • University of New Hampshire School of Law, Masters in Intellectual Property, 2014
  • University of Wisconsin-Madison, Ph.D., Chemistry, 1994
  • Florida State University, Bachelors of Science, Chemistry, 1988
  • U.S. Patent and Trademark Office
  • Overview

    Adolph brings 14 years of experience as a research chemist in the pharmaceutical industry, 2 years of experience teaching chemistry at the college level, and 4 years of experience in the preparation and prosecution of patent applications as a registered patent agent.

    Adolph’s research experience in industry includes hit discovery via combinatorial chemistry libraries, hit-to-lead, lead optimization, and process research on small molecule compounds. The targets of his research include kinase inhibitors (Lck, JAK3, and c-MET), GPCRs (CB-1 and CXCR2), and the transporter GlyT2.

    Adolph has taught Basic Chemistry, Organic Chemistry I and II, and Introductory Biochemistry at SUNY-Adirondack and Franklin Pierce University.

    Adolph’s current focus is the preparation and prosecution of patents protecting small molecule therapeutics.

  • Speaking Engagements
    • “Synthesis Studies on Cephalotaxus Alkaloids” Ken S. Feldman and Adolph C. Bohnstedt at the 211th ACS National Meeting, New Orleans, LA, March 24-28 (1996), ORGN 056.
    • “Synthesis of Conformationally Constrained Analogues of Cyclosporin A” A. C. Bohnstedt and D. H. Rich at the 207th ACS National Meeting, San Diego, CA, March 13-17 (1994), ORGN 037.
    • “The Synthesis of Trans- and Cis-alkene Dipeptide Isosteres for Incorporation into Cyclosporin A Analogs” A. C. Bohnstedt, J. V. N. Vara Prasad, and D. H. Rich at the 206th ACS National Meeting, Chicago, IL, August 22-27 (1993), ORGN 304.
  • Publications
    • “2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors” Bioorg. Med. Chem. Lett. 2009, 19, 6788-6792.
    • “Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists” Bioorg. Med. Chem. Lett. 2006, 16, 2724-2728.
    • “2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors” Bioorg. Med. Chem. Lett. 2004, 14, 545-548.
    • “Inter- and Intramolecular Addition/Cyclizations of Sulfonamide Anions with Alkynyliodonium Triflates. Synthesis of Dihydropyrrole, Pyrrole, Indole, and Tosylenamide Heterocycles” Ken S. Feldman, Michelle M. Bruendl, Klaas Schildknegt, and Adolph C. Bohnstedt J. Org. Chem. 1996, 61, 5440-5452.
    • “Intramolecular Bicyclizations of Tosylamide-Containing Alkynyliodonium Salts as an Efficient Entry into Polycyclic Alkaloid Skeleta” Klaas Schildknegt, Adolph C. Bohnstedt, Ken S. Feldman, and Aruna Sambandam J. Am. Chem. Soc. 1995, 117, 7544-7545.
    • “Differential Sensitivity of Cyclosporin A Amide Bonds for Inhibition of Cyclophilin” A. C. Bohnstedt, G. R. Flentke, and D. H. Rich In Peptides: Chemistry-Structure-Biology. Proceedings of the 14th American Peptide Symposium; Kaumaya, Pravin T. P., Hodges, Robert S., Eds.; Mayflower Scientific: Kingswinford, UK, 1996; pp 705-706.
    • “Synthesis of E- and Z-alkene Dipeptide Isosteres” Adolph C. Bohnstedt, J. V. N. Vara Prasad, and Daniel H. Rich Tetrahedron Lett. 1993, 34, 5217-5220.
  • Education
    • University of New Hampshire School of Law, Masters in Intellectual Property, 2014
    • University of Wisconsin-Madison, Ph.D., Chemistry, 1994
    • Florida State University, Bachelors of Science, Chemistry, 1988
  • Admissions
    • U.S. Patent and Trademark Office